Bloomage BioTechnology Corporation Limited (SHA:688363)
China · Delayed Price · Currency is CNY 35.04
+0.38 (1.10%)
Nov 5, 2026, 3:00 PM CST
SHA:688363 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 225.77 | 292.06 | 174.27 | 592.56 | 970.92 | 782.33 |
Depreciation & Amortization | 346.57 | 350.09 | 300 | 264.65 | 213.61 | 154.33 |
Other Amortization | 44.43 | 40.91 | 30.18 | 27.74 | 15.04 | 6.96 |
Loss (Gain) From Sale of Assets | -0.22 | -0.22 | 0.12 | 3.42 | 0.49 | -0.04 |
Asset Writedown & Restructuring Costs | 5.22 | 5.22 | 74.95 | 1.87 | 0.28 | 33.73 |
Loss (Gain) From Sale of Investments | -14.15 | -14.15 | 11.48 | 17.41 | -11.77 | -28.04 |
Provision & Write-off of Bad Debts | 41.46 | 41.46 | 26.01 | 7.6 | 15.36 | 5.78 |
Other Operating Activities | 439.42 | 102.49 | 85.03 | 30.02 | -1.72 | -1.65 |
Change in Accounts Receivable | -38.99 | -38.99 | -86.55 | 54.48 | -98.43 | -36.27 |
Change in Inventory | 200.26 | 162.15 | -141.49 | 13.88 | -437.82 | -218.53 |
Change in Accounts Payable | -327.97 | -327.97 | 98.06 | -321.54 | -72.85 | 613.39 |
Change in Other Net Operating Assets | -43.39 | -5.28 | 11.54 | 42.5 | 103.85 | 114.25 |
Operating Cash Flow | 898.09 | 627.45 | 564.51 | 699.65 | 635.19 | 1,276 |
Operating Cash Flow Growth | 49.88% | 11.15% | -19.32% | 10.15% | -50.22% | 80.97% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -367.9 | -325.68 | -721.39 | -1,030 | -696.41 | -784.21 |
Sale of Property, Plant & Equipment | 0.16 | 2.07 | 0.21 | 0 | 1.24 | 0.01 |
Cash Acquisitions | - | - | - | - | -155.15 | -138.09 |
Divestitures | - | - | - | - | 0.12 | - |
Investment in Securities | -46.74 | 48.32 | 227.02 | 403.67 | -11.17 | -100.1 |
Other Investing Activities | -241.08 | 10.42 | 32.79 | 13.78 | 25.15 | 32.53 |
Investing Cash Flow | -655.57 | -264.87 | -461.37 | -612.88 | -836.22 | -989.86 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 310.28 | 149.9 | - | 137.83 | 174 |
Total Debt Issued | 239.88 | 310.28 | 149.9 | - | 137.83 | 174 |
Long-Term Debt Repaid | - | -259.02 | -160.4 | -173.91 | -84.62 | -54.32 |
Lease Payments | -56.39 | -56.39 | -46.22 | -67.54 | -47.9 | -38.14 |
Total Debt Repaid | -239.61 | -259.02 | -160.4 | -173.91 | -84.62 | -54.32 |
Net Debt Issued (Repaid) | 0.26 | 51.26 | -10.51 | -173.91 | 53.21 | 119.68 |
Issuance of Common Stock | - | - | - | 51.72 | 84.21 | - |
Repurchase of Common Stock | - | - | -114.08 | -105.89 | - | - |
Common Dividends Paid | -96.51 | -56.08 | -185.93 | -305.48 | -242.86 | -201.01 |
Other Financing Activities | 19.11 | 2.52 | - | 6 | -64.71 | 9.98 |
Financing Cash Flow | -77.14 | -2.3 | -310.52 | -527.57 | -170.16 | -71.36 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -29.71 | 4 | 7.81 | 10.56 | 29.56 | -19.85 |
Net Cash Flow | 135.67 | 364.28 | -199.57 | -430.24 | -341.63 | 194.99 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 530.19 | 301.77 | -156.88 | -330.68 | -61.22 | 491.85 |
Free Cash Flow Growth | 124.07% | - | - | - | - | - |
Free Cash Flow Margin | 14.60% | 7.19% | -2.92% | -5.44% | -0.96% | 9.94% |
Free Cash Flow Per Share | 1.12 | 0.63 | -0.32 | -0.69 | -0.13 | 1.02 |
Levered Free Cash Flow | 139.61 | 221.1 | -288.5 | -624.83 | -240.37 | 940.17 |
Unlevered Free Cash Flow | 141.43 | 225.11 | -282.77 | -618.13 | -231.29 | 947.09 |
Free Cash Flow After Leases | 473.8 | 245.38 | -203.1 | -398.23 | -109.13 | 453.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 208.49 | 226.04 | 480.27 | 550.54 | 770.79 | 539.9 |
Change in Working Capital | -190.41 | -190.41 | -137.54 | -245.63 | -567.02 | 322.66 |